Symbol Name ID |
Lamtor2
late endosomal/lysosomal adaptor, MAPK and MTOR activator 2 MGI:1932697 |
Allelic Composition Genetic Background |
Annotated Term | Reference |
Lamtor2tm1.1Lah/Lamtor2tm1.1Lah Meox2tm1(cre)Sor/Meox2+ involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6 |
embryonic lethality during organogenesis, complete penetrance | J:119075 |
Lamtor2tm1.1Lah/Lamtor2tm1.1Lah Tg(KRT5-cre)1Tak/0 involves: 129P2/OlaHsd * C3H * C57BL/6 * SJL |
abnormal epidermal layer morphology | J:119075 |
abnormal epidermis stratum corneum morphology | J:119075 | |
abnormal epidermis stratum granulosum morphology | J:119075 | |
abnormal skin condition | J:119075 | |
decreased cell proliferation | J:119075 | |
impaired skin barrier function | J:119075 | |
neonatal lethality, complete penetrance | J:119075 | |
reddish skin | J:119075 | |
thin epidermis | J:119075 | |
Lamtor2tm1.2Lah/Lamtor2tm1.2Lah involves: 129P2/OlaHsd * C57BL/6 * SJL |
abnormal embryonic tissue morphology | J:119075 |
embryonic growth retardation | J:119075 | |
embryonic lethality during organogenesis, complete penetrance | J:119075 |
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 12/10/2024 MGI 6.24 |
|
|